Labiana Health (XMAD:LAB) Other Financing : €0.00 Mil (TTM As of Dec. 2022)

View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Other Financing?

Labiana Health's Other Financing for the six months ended in Dec. 2022 was €0.00 Mil.

Labiana Health's Other Financing for the trailing twelve months (TTM) ended in Dec. 2022 was €0.00 Mil.

Labiana Health Other Financing Historical Data

The historical data trend for Labiana Health's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Other Financing Chart

Labiana Health Annual Data

Trend

Dec20

Dec21

Dec22

Other Financing

-1.78

4.37

-3.11

Labiana Health Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22
Other Financing	-	-	-	-

Labiana Health Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Labiana Health Other Financing Related Terms

Thank you for viewing the detailed overview of Labiana Health's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Labiana Health (XMAD:LAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Other Financing

Traded in Other Exchanges

N/A

Address

Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023

Website

https://www.labiana.com

Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.